Search results
Diabetes drug Ozempic reduces risk of death from kidney disease
Interesting Engineering· 6 hours agoThe research suggests that Ozempic, commonly used to treat diabetes, may offer significant benefits...
Ozempic reduces risk of serious illness and death in people with diabetes and kidney disease, study...
CNN via Yahoo News· 2 days agoWeekly injections of semaglutide medications like Ozempic significantly reduce the risk of serious...
Semaglutide significantly reduces risk of complications in patients with type 2 diabetes, study...
Medical Xpress· 1 day agoA pioneering study has demonstrated that semaglutide significantly reduces the risk of major kidney disease events, cardiovascular outcomes, and all-cause mortality in patients ...
Study: Ozempic boosts health, survival of patients with kidney disease, Type 2 diabetes
United Press International via Yahoo News· 1 day agoThe results were also published in the New England Journal of Medicine. "These findings offer great...
FDA Advisors Not Convinced Once-Weekly Insulin Is Safe in Type 1 Diabetes
MedPage Today· 2 days agoAn FDA advisory committee mostly agreed on Friday that an investigational once-weekly insulin...
Semaglutide use tied to lower kidney disease risk in obesity
Medical News Today· 12 hours agoBoth obesity and cardiovascular disease can increase a person’s risk of developing kidney disease. A...
FDA advisers weigh benefits of weekly insulin for people with diabetes
CNN via Yahoo News· 1 day agoMost types of insulin therapy, an important part of diabetes treatment for many people, are given as...
Could drugs like Ozempic and Wegovy help people live longer? Some experts see them as potential...
Fortune· 7 minutes agoIt’s the question many scientists are asking about the controversial drug, a glucagon-like peptide-1 receptor agonist (GLP-1), as some research suggests it could help humans age with less chronic ...
Georgia teenager among first patients to receive type 1 diabetes-delaying treatment
WSB Cox articles via Yahoo News· 15 hours agoAfter two years, the family said her condition started to decline to a point where she was at risk...
FDA panel votes against Novo Nordisk's weekly insulin in type 1 diabetes patients
CNBC· 23 hours agoThe comments come after the FDA's staff on Wednesday flagged therisk of low blood sugar in type 1 ...